Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
25.89
-1.10 (-4.08%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $2.13 billion as of April 28, 2026. Its market cap has increased by 169.93% in one year.
Market Cap
2.13B
Enterprise Value
1.48B
1-Year Change
169.93%
Ranking
Category
Stock Price
$25.89
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $2.13B, an increase of 241.60%. That is a compound annual growth rate of 46.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 2.23B | -22.51% |
| Dec 31, 2025 | 2.87B | 368.78% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zai Lab | 2.47B |
| Ultragenyx Pharmaceutical | 2.39B |
| Tyra Biosciences | 2.20B |
| Adaptive Biotechnologies | 2.19B |
| Ascentage Pharma Group International | 2.17B |
| Sarepta Therapeutics | 2.16B |
| Definium Therapeutics | 2.14B |
| Aurinia Pharmaceuticals | 2.14B |